CB Boosts Shareholder Value With Dividends, Okays Buyback Program
Chubb Limited raises its dividend for the 33rd straight year and approved a new $7.5B buyback plan, underscoring confidence in cash flow and capital strength.
CB - Chubb Limited
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$344.33
DETAILS
HIGH:
$373.00
LOW:
$309.00
MEDIAN:
$343.00
CONSENSUS:
$344.33
UPSIDE:
5.01%
Stock News
Why Is Chubb (CB) Up 0.9% Since Last Earnings Report?
Chubb (CB) reported earnings 30 days ago. What's next for the stock?
Chubb Limited Shareholders Approve 33rd Consecutive Annual Dividend Increase; Chubb Limited Board Declares Record Date for First Dividend Installment and Authorizes New Share Repurchase Program
Chubb Limited Shareholders Approve 33rd Consecutive Annual Dividend Increase; Chubb Limited Board Declares Record Date for First Dividend Insta
Here's Why Chubb (CB) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Chubb Limited Shareholders Approve 33rd Consecutive Annual Dividend Increase; Chubb Limited Board Declares Record Date for First Dividend Installment and Authorizes New Share Repurchase Program
ZURICH, May 21, 2026 /PRNewswire/ -- Chubb Limited (NYSE: CB) announced today that at its 2026 Annual General Meeting, held at the company's offices in Zurich, Switzerland, shareholders approved a 5.2% increase in the company's dividend to $4.08 per share annually ($1.02 per share, per quarter) from $3.88 per share ($0.97 per share, per quarter). This marks the 33rd consecutive annual increase in the company's dividend.
AM Best Assigns Issue Credit Rating to Chubb INA Holdings LLC's Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “a+” (Excellent) to Chubb INA Holdings LLC's (Chubb) (Delaware) recently announced USD 1.0 billion issuance of 5.3% senior unsecured notes due 2036 in the U.S. market, which are guaranteed by Chubb Limited. The outlook assigned to this Credit Rating is stable. Chubb intends to use the net proceeds from this offering for general corporate purposes, which may include the redemption, repurchase or repayment of.
The Issuers Pulling Ahead Are Building Into Customers' Money Flows
The competition among card issuers is no longer centered only on rewards rates or promotional offers. Increasingly, it is about whether an issuer can become embedded deeply enough in a customer's daily financial activity that the relationship becomes difficult to displace.
Chubb Limited Announces Pricing of $1 Billion Senior Notes Offering by Subsidiary
ZURICH, May 18, 2026 /PRNewswire/ -- Chubb Limited (NYSE: CB) announced today that its subsidiary, Chubb INA Holdings LLC, has priced a public offering of $1 billion of 5.30% senior notes due 2036 (the "2036 Notes"). The 2036 Notes are guaranteed by Chubb Limited.
AM Best Assigns Issue Credit Ratings to Chubb INA Holdings LLC's Senior Unsecured Bonds
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned Long-Term Issue Credit Ratings of “a+” (Excellent) to Chubb INA Holdings LLC (Chubb) (Delaware) recently announced CNY 4.0 billion (approximately USD 586 million) issuance of senior unsecured bonds in the Hong Kong market in two tranches, which are guaranteed by Chubb Limited: CNY 2.5 billion 2.4% senior unsecured bonds due 2031; and CNY 1.5 billion 2.85% senior unsecured bonds due 2036. The outlook assigned to these Credit Ratings (rating) i.
Here is What to Know Beyond Why Chubb Limited (CB) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Chubb (CB). This makes it worthwhile to examine what the stock has in store.
Here's How CB's Technology Investments Support Long-Term Growth
Chubb Limited is betting big on AI and digital transformation, targeting lower costs, automated processes, and stronger underwriting profitability.
Palomar Q1 Earnings, Revenues Top Estimates, Investment Income Rises Y/Y
PLMR beat Q1 estimates as revenues jump 58.7% on higher premiums and investment income despite rising expenses and weaker underwriting income.
Why Chubb (CB) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Verified Clinical Trials y Chubb anuncian una alianza estratégica
/PRNewswire/ -- Verified Clinical Trials (VCT), líder mundial en soluciones de registro de sujetos para ensayos clínicos, y Chubb anunciaron hoy una alianza
Unum Group Q1 Earnings Miss Estimates, Revenues Rise Y/Y
UNM Q1 earnings miss estimates as higher benefit costs and weaker international results offset premium growth and strong sales momentum.
Verified Clinical Trials et Chubb annoncent une alliance stratégique pour améliorer la sécurité des sujets de la recherche clinique, accroître la qualité des données et favoriser la réussite des essais cliniques
/PRNewswire/ -- Verified Clinical Trials (VCT), leader mondial des solutions de registre de sujets d'essais cliniques, et Chubb ont annoncé aujourd'hui une
Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success
BOCA RATON, Fla., April 28, 2026 /PRNewswire/ -- Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, and Chubb today announced a strategic alliance focused on enhancing research subject safety, improving data quality, strengthening study integrity, and supporting successful clinical trial outcomes.
Chubb Limited (CB) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Chubb (CB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Berkshire Trades Below 50-Day SMA: What Should Investors Know?
BRK.B slid below its 50-day SMA, flashing a bearish signal. Valuation looks rich, and sentiment is mixed.
Chubb: Still Boring, Still Profitable
Chubb delivers exceptional underwriting stability, with a 10-year combined ratio of 89.6% and 84% in Q1 2026. CB's expanding life insurance segment delivered 34% premium growth and now contributes 9% of consolidated segment income, enhancing diversification. FY2026 net income is expected between $8.6B and $10.9B, implying a valuation of 11.6x–14.7x earnings and up to 20% upside.
Price Targets
Chubb price target raised to $333 from $321 at Wells Fargo
$333.00
(was $325.43)
Elyse Greenspan
·
Wells Fargo
Chubb price target raised to $326 from $286 at BMO Capital
$326.00
(was $326.17)
Michael Zaremski
·
BMO Capital
Chubb price target raised to $340 from $320 at UBS
$340.00
(was $331.56)
UBS
Chubb Corporation (CB) PT Raised to $373 at KBW as 'Strength Persists'
$373.00
(was $330.70)
Seaport Global
Chubb price target raised to $336 from $317 at Mizuho
$336.00
(was $331.28)
Mizuho Securities
Chubb price target raised to $366 from $351 at Goldman Sachs
$366.00
(was $331.28)
Goldman Sachs
Chubb price target raised to $360 from $330 at Roth Capital
$360.00
(was $332.15)
Roth Capital
Chubb upgraded to Buy from Hold at HSBC
$354.00
(was $299.96)
HSBC
Chubb Corporation (CB) PT Raised to $350 at Citizens: 'Superb Global Franchise'
$350.00
(was $301.11)
Morgan Stanley
Chubb price target lowered to $317 from $318 at Mizuho
$317.00
(was $300.69)
Mizuho Securities
Chubb price target raised to $309 from $300 at Cantor Fitzgerald
$309.00
(was $300.69)
Cantor Fitzgerald
Chubb price target raised to $305 from $293 at Wells Fargo
$305.00
(was $306.62)
Wells Fargo
Chubb price target raised to $339 from $317 at Barclays
$339.00
(was $306.63)
Barclays
Chubb upgraded to Buy at Goldman Sachs on diversification
$351.00
(was $306.63)
Robert Cox
·
Goldman Sachs
Chubb price target raised to $346 from $315 at Evercore ISI
$346.00
(was $307.51)
David Motemaden
·
Evercore ISI
Chubb price target raised to $310 from $300 at Morgan Stanley
$310.00
(was $312.54)
Bob Huang
·
Morgan Stanley
Chubb initiated with a Neutral at Mizuho
$318.00
(was $312.54)
Mizuho Securities
Chubb Corporation (CB) PT Raised to $309 at Goldman Sachs
$309.00
(was $281.68)
Alex Scott
·
Goldman Sachs
Chubb price target raised to $298 from $292 at UBS
$298.00
(was $281.02)
UBS
Chubb price target raised to $300 from $290 at Cantor Fitzgerald
$300.00
(was $281.12)
Cantor Fitzgerald